sarcoidosis
NHLBI Funds ATT Deficiency, Sarcoidosis Studies
A two-track, $12 million grant program seeks to identify molecular factors involved in two diseases that affect the lungs.
Details of the deal are sparse, but the partners said they hope their research will lead to the development of genetic tests that can gauge patients’ predisposition to rare diseases and help target individuals most likely to respond to drugs made by MondoBiotech.